These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 28204917)
21. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy. Leyva F; Zegard A; Acquaye E; Gubran C; Taylor R; Foley PWX; Umar F; Patel K; Panting J; Marshall H; Qiu T J Am Coll Cardiol; 2017 Sep; 70(10):1216-1227. PubMed ID: 28859784 [TBL] [Abstract][Full Text] [Related]
22. Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry. Frommeyer G; Andresen D; Ince H; Maier S; Stellbrink C; Kleemann T; Seidl K; Hoffmann E; Zrenner B; Hochadel M; Senges J; Eckardt L Heart Vessels; 2019 Jul; 34(7):1196-1202. PubMed ID: 30607538 [TBL] [Abstract][Full Text] [Related]
23. Early Implantation of Primary Prevention Implantable Cardioverter Defibrillators for Patients with Newly Diagnosed Severe Nonischemic Cardiomyopathy. Voskoboinik A; Bloom J; Taylor A; Mariani J Pacing Clin Electrophysiol; 2016 Sep; 39(9):992-8. PubMed ID: 27343008 [TBL] [Abstract][Full Text] [Related]
24. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490 [TBL] [Abstract][Full Text] [Related]
25. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia. Evonich RF; Maheshwari A; Gardiner JC; Khasnis A; Kantipudi S; Ip JH; Grimes D; Hayter G; Thakur RK J Interv Card Electrophysiol; 2004 Aug; 11(1):59-65. PubMed ID: 15273456 [TBL] [Abstract][Full Text] [Related]
26. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study. Wang NC; Singh M; Adelstein EC; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S Heart Rhythm; 2016 Apr; 13(4):933-42. PubMed ID: 26688064 [TBL] [Abstract][Full Text] [Related]
27. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. Lee TC; Qian M; Mu L; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Lip GYH; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S; ESC Heart Fail; 2019 Apr; 6(2):297-307. PubMed ID: 30816013 [TBL] [Abstract][Full Text] [Related]
28. Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar. Gutman SJ; Costello BT; Papapostolou S; Voskoboinik A; Iles L; Ja J; Hare JL; Ellims A; Kistler PM; Marwick TH; Taylor AJ Eur Heart J; 2019 Feb; 40(6):542-550. PubMed ID: 30107489 [TBL] [Abstract][Full Text] [Related]
29. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833 [TBL] [Abstract][Full Text] [Related]
30. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796 [TBL] [Abstract][Full Text] [Related]
31. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276 [TBL] [Abstract][Full Text] [Related]
32. Yield of left ventricular dyssynchrony by gated SPECT MPI in patients with heart failure prior to implantable cardioverter-defibrillator or cardiac resynchronization therapy with a defibrillator: Characteristics and prediction of cardiac outcome. Zafrir N; Bental T; Strasberg B; Solodky A; Mats I; Gutstein A; Kornowski R J Nucl Cardiol; 2017 Feb; 24(1):122-129. PubMed ID: 26563336 [TBL] [Abstract][Full Text] [Related]
34. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis. Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177 [TBL] [Abstract][Full Text] [Related]
35. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Barsheshet A; Goldenberg I; Moss AJ; Eldar M; Huang DT; McNitt S; Klein HU; Hall WJ; Brown MW; Goldberger JJ; Goldstein RE; Schuger C; Zareba W; Daubert JP Eur Heart J; 2011 Jul; 32(13):1622-30. PubMed ID: 21075774 [TBL] [Abstract][Full Text] [Related]
36. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy. McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886 [TBL] [Abstract][Full Text] [Related]
37. Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator. Zhou B; Zhao S; Tang M; Chen K; Hua W; Su Y; Chen S; Liang Z; Xu W; Li X; Xue X; Sun X; Zhang S Clin Cardiol; 2020 Dec; 43(12):1435-1442. PubMed ID: 32936479 [TBL] [Abstract][Full Text] [Related]